Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

Citi upgraded Charles River Laboratories (NYSE:CRL) and LabCorp (NYSE:LH) while downgrading Quest Diagnostics (NYSE:DGX), ...

Citi upgraded Labcorp (LH) to Buy from Neutral with a price target of $300, up from $250. Utilization rates have been running high ...

Shares of Labcorp Holdings Inc. LH rose 1.31% to $251.04 Friday, on what proved to be an all-around positive trading session ...

On Jan. 24, the U.S. Supreme Court agreed to take up a petition filed by Laboratory Corp. of America on whether judges should ...

A Durham company with a slumping stock is implementing changes to its board after reaching a deal with an activist investor.

This was the stock's second consecutive day of losses.

Labcorp (LH) announced the clinical availability of Labcorp Plasma Complete, a circulating tumor DNA-based comprehensive genomic profiling ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM, a circulating tumor DNA (ctDNA)-based ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings tomorrow before the bell. Here’s what to look for. Labcorp met analysts’ revenue expectations last quarter ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...